Avirmax CMC

We deliver high quality & quantity of rAAV vectors through Innovation and a Robust manufacturing platform
To Serve Our Clients Reliably, Transparently and Timely
Read More

About Avirmax CMC Inc.

Avirmax CMC Inc. based in the SF Bay Area, is dedicated to develop the state-of-the-art technologies to address current challenges in the recombinant adeno-associated virus (rAAV) bioprocess development and manufacturing using its proprietary rAAV production platforms based on the Bac-to-AAV and HEK293 technologies to provide rAAV services from DNA Sequences into final Gene Therapy Products for Clinical Investigation.


Non GMP rAAV and Plasmid DNA Services

GMP rAAV Products for Clinical Investigation